Caffeine
Introduction to Caffeine
Caffeine is a methylxanthine, an alkaloid from plant origins.
Other methylxanthines include theophylline and theobromine.
Caffeine Sources
Common sources include coffee, tea, and chocolate with varying caffeine concentrations.
Caffeine Consumption
Estimated average global consumption: ~70 mg/day.
US average: nearly 170 mg/day, rising to 186 mg/day.
90% of the population consumes caffeine products.
Pharmacology of Caffeine
Mechanisms of action:
Inhibition of phosphodiesterase.
Release of calcium from stores.
Antagonism of adenosine receptors (primary action).
Caffeine leads to increased dopamine levels but may impact receptor efficiency at high doses.
Pharmacokinetics
Absorption: Rapid, peak concentrations in 15-45 minutes.
Distribution: Uniform throughout the body.
Metabolism: Primarily in the liver; excreted mostly by kidneys.
Tolerance and Dependence
Tolerance develops, especially for physiological effects (renal, sleep, etc.), less for stimulant effects.
Withdrawal symptoms commonly include headache and fatigue.
Acute Effects
Behavioral effects: Increased energy, alertness, and mood elevation.
Can impair decision-making despite increased motor performance.
Interactions with Other Substances
Caffeine, nicotine, and alcohol commonly used together.
Can mask alcohol's effects, may lead to binge drinking.
Acute Toxicity
Symptoms can occur from as little as 250 mg of caffeine.
Risk increases above 1,000 mg.
Lethal dose estimated around 10 grams (approximately 75 cups of coffee).
Chronic Effects
Low to moderate caffeine intake shown not to affect reproduction or significant health outcomes.
Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).
Concluding Notes
Overall, caffeine is considered relatively safe; interactions with other variables are still being researched.
Origin Source
Caffeine is a methylxanthine, an alkaloid from plant origins.
Common sources include coffee, tea, and chocolate with varying caffeine concentrations.
Production Uses
Information on specific production uses is not detailed in the provided notes.
Benefits
Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).
Administration
Information on specific administration methods is not detailed in the provided notes, though it is consumed through common sources like coffee, tea, and chocolate.
Mechanism of Action
Mechanisms of action:
Inhibition of phosphodiesterase.
Release of calcium from stores.
Antagonism of adenosine receptors (primary action).
Caffeine leads to increased dopamine levels but may impact receptor efficiency at high doses.
Pharmacokinetics
Absorption: Rapid, peak concentrations in 15-45 minutes.
Distribution: Uniform throughout the body.
Metabolism: Primarily in the liver; excreted mostly by kidneys.
Acute Effects
Behavioral effects: Increased energy, alertness, and mood elevation.
Can impair decision-making despite increased motor performance.
Chronic Effects
Low to moderate caffeine intake shown not to affect reproduction or significant health outcomes.
Potential benefits include prevention of certain diseases (e.g., Parkinson's, type 2 diabetes).
Tolerance and Dependence
Tolerance develops, especially for physiological effects (renal, sleep, etc.), less for stimulant effects.
Withdrawal symptoms commonly include headache and fatigue.
Trends (Consumption)
Estimated average global consumption: mg/day.
US average: nearly mg/day, rising to mg/day.
% of the population consumes caffeine products.
Variables Impacting Use
Caffeine, nicotine, and alcohol commonly used together.
Can mask alcohol's effects, may lead to binge drinking.
Interactions with other variables are still being researched.